Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-4344
ISSN (Online): 2772-4352

Research Article

Comparing India's Second COVID Wave with the First Wave-A Single-Center Experience

Author(s): Mayank Kapoor, Budha O Singh, Prasan Kumar Panda*, Pathik Dhanger and Anant Kataria

Volume 17, Issue 3, 2022

Published on: 18 August, 2022

Page: [178 - 186] Pages: 9

DOI: 10.2174/2772434417666220628153110

Price: $65

Abstract

Background: The COVID-19 pandemic has resurfaced in India as a hardhitting second wave. This study aims to compare the clinical profile of the first wave (April-June 2020) and the second wave (March-May 2021) of the severe acute respiratory syndrome coronavirus-2 pandemic (SARS-CoV-2) in a single tertiary care center in India.

Methods: In this retrospective observational study, we examined the demographic profile, symptoms at presentation, severity of illness, baseline investigations, treatments received, underlying comorbidities, and outcomes of the COVID-19 patients belonging to the first (W1) and the second wave (W2) of the pandemic in India.

Results: The age group affected most in the W2 is 50.5 (17.7) versus 37·1 (16·9) years for W1. The baseline oxygen saturation is lower in W2, being 84·0 (13·4) % compared with 91·9 (7·4) % in W1 [SpO2 < 90% OR 14.3 (6.1-33), P < 0.0001]. 70.2 % of the cases belonged to the severe category in W2 compared to 37.5% in W1. W2 has worse outcomes. Incidence of acute respiratory distress syndrome (ARDS) [48.7% v/s 6.45%; OR 15.4 (6.5-35.7), P<0.0001], Acute Kidney Injury (AKI) [18% v/s 2.4%; OR 6 (1.7- 22.2), P = 0.005], Acute Liver Injury (transaminitis) [12.8% v/s 6.4%, OR 7.3 (3.7- 14.3), P < 0.0001], and deaths (29% v/s 9.6%, standardized mortality ratio 3.5) is higher in W2. Similarly, the CT severity score for W2 [29.5 (6.7)] was higher than W1 [23·2 (11·5), P < 0.05]. The proportion of patients requiring oxygen [81.8% v/s 11.2%; OR 125 (40-333.3), P < 0.0001], high flow nasal cannula (HFNC) (11.4% v/s 5.6%), Non- Invasive Ventilation (NIV) (41.2% v/s 1.5%), invasive ventilation [24.5% v/s 0.9%; OR 22.72 (2.94-166.6), P = 0.003], as well as ICU/HDU admissions [56.4% v/s 12.0%; OR 10.5 (5.3-21.2), P < 0.0001] was higher for W2 as compared with W1. Cough, invasive ventilation, inotrope requirement, and ARDS are significantly related to higher mortality in the W2 than W1.

Conclusion: Higher age, oxygen requirement, ventilator requirement, ICU admission, and organ failure are more prevalent in the admitted COVID-19 cases during the second wave that hit India than in the first wave and are associated with more fatalities. Strategy for another wave should be planned accordingly.

Keywords: Coronavirus disease, COVID waves, demography, pandemic, SARS-CoV-2, mortality.

Graphical Abstract
[1]
England imposes new national lockdown to combat COVID-19 resurgence. Reuters Available from: https://www.reuters.com/article/uk-health-coronavirus-britain-lockdown/england-imposes-new-national-lockdown-to-combat-covid-19-resurgence-idUKKBN27G0TM?edition-redirect=uk (Accessed on Jun 07, 2022).
[2]
Explained: What has changed in second wave of Covid- 19? | Explained News,The Indian Express Available from: https://indianexpress.com/article/explained/explained-whats-changed-in-second-wave-7289002/ (Accessed on Jun 07, 2022).
[3]
PANGO lineages. Available from: https://cov-lineages.org/lineages/lineage_B.1.617.html (Accessed on Jun 07, 2022).
[4]
Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 2020; 117(21): 11727-34.
[http://dx.doi.org/10.1073/pnas.2003138117] [PMID: 32376634]
[5]
Mortality Analyses - Johns Hopkins Coronavirus Resource Center. Available from: https://coronavirus.jhu.edu/data/mortality (Accessed on Jun 07, 2022).
[6]
Bajaj D, Rawat V, Malik K, Kukreja WN. The COVID-19 havoc and clues from Sex disaggregated data in the Indian population. J Integr Sci Technol 2022; 10(1): 29-38.
[7]
Sarkar A, Chakrabarti AK, Dutta S. Covid-19 infection in India: A comparative analysis of the second wave with the first wave. Pathogens 2021; 10(9): 1222.
[http://dx.doi.org/10.3390/pathogens10091222] [PMID: 34578254]
[8]
Singh V, Choudhary A, Datta MR, Ray A. Maternal and neonatal outcome of pregnant women with SARS-CoV-2 In-fection during the first and second wave of COVID-19 in a tertiary care institute in eastern India. Cureus 2022; 14(2): e22360.
[http://dx.doi.org/10.7759/cureus.22360] [PMID: 35371690]
[9]
COVID-19 oxygen emergency impacting more than half a million people in low- and middle-income countries every day, as demand surges. Available from: https://www.who.int/news/item/25-02-2021-covid-19-oxygen-emergency-impacting-more-than-half-a-million-people-in-low--and-middle-income-countries-every-day-as-demand-surges (Accessed on Jun 07, 2022).
[10]
Coronavirus (COVID-19) Hospitalizations - Our World in Data. Available from: https://ourworldindata.org/covid-hospitalizations (Accessed on Jun 07, 2022).
[11]
Kapoor M, Panda PK, Mohanty V. Pharmacotherapy for COVID-19: A Ray of Hope. Fight COVID-19 Pandemic 2021. Available from: https://www.intechopen.com/chapters/75843 (Accessed on Jun 07, 2022).
[12]
Mucormycosis: The “black fungus” maiming Covid patients in India - BBC News Available from: https://www.bbc.com/news/world-asia-india-57027829 (Accessed on Jun 07, 2022).
[13]
Lascarrou JB. COVID-19-related ARDS: One disease, two trajectories, and several unanswered questions. Lancet Respir Med 2021; 9(12): 1345-7.
[http://dx.doi.org/10.1016/S2213-2600(21)00381-7] [PMID: 34653373]
[14]
Gibson PG, Qin L, Puah SH. COVID‐19 Acute Respiratory Distress Syndrome (ARDS): Clinical features and differen-ces from typical pre‐COVID‐19 ARDS. Med J Aust 2020; 213(2): 54-56.e1.
[15]
Batlle D, Soler MJ, Sparks MA, et al. Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysio-logy. J Am Soc Nephrol 2020; 31(7): 1380-3.
[http://dx.doi.org/10.1681/ASN.2020040419] [PMID: 32366514]
[16]
Ghoda A, Ghoda M. Liver Injury in COVID-19 infection: A systematic review. Cureus 2020; 12(7): 9487.
[17]
Job S, Kapoor M, Panda PK, Mohan L. COVID-19 prevention protocol for an organised mass gatheringan essential requisite in pandemic and post-pandemic phase. J Clin Diagnostic Res 2021. Available from: https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=4&page=IM01&issn=0973-709x&id=14713
[18]
Jha P, Deshmukh Y, Tumbe C, et al. COVID mortality in India: National survey data and health facility deaths. Science (80- ) 2022; 375(6581): 667-71
[19]
Kavitha C, Gowrisankar A, Banerjee S. The second and third waves in India: When will the pandemic be culminated? Eur Phys J Plus 2021; 136(5): 596.
[http://dx.doi.org/10.1140/epjp/s13360-021-01586-7] [PMID: 34094795]
[20]
Clinical Management Protocol For COVID-19 (In Adults). Government of India: Ministry of Health and Family Welfare. Available from: https://www.mohfw.gov.in/pdf/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf (Accessed on Jun 07, 2022).

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy